Therapeutic

Therapeutic Market Research Reports

Therapeutic Market Research Reports, Analysis & Trends

 

Sub-Categories

Oncology (62)
Publication Single User License (PDF) Price
Snapshot on Oncology Medicine Market in India - 2015; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Snapshot on Oncology Medicine Market in India - 2015; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Date Published: Mar 6 2015

Snapshot on Oncology Medicine Market in India - 2015 report provides an insight into the Oncology Medicine current market scenario, structure and practices in India.

In depth market scenario includes;
- Market estimate of Oncology Medicine in India for FY14
- Geographical presence of key players in India
- Providing insights into Industry drivers and challenges and their impact on the future market
- Regulatory bodies and their roles
- Future Market projections for 5 years
- Opportunities in the Industry

$2,000.00
Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success

Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success

Date Published: Jan 26 2015
All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a positive return and hence increased the interest of biotech investors.  These companies have been able to select therapy/niche indication where the high treatment cost justifies the need.  While large pharma companies are active in M&A deals, the Mature biotech companies are sticking to its core expertise and venturing into unexplored/new therapy; e.g., GILD in anti-cancer and BIIB for hemophilia.
$2,000.00
Regenerative Medicine and Stem cell based Cell therapies-Drugs of the Future Offering Hope for Cure

Regenerative Medicine and Stem cell based Cell therapies- Drugs of the Future Offering Hope for Cure

Date Published: Jan 22 2015
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology are discovered. Improved health care, nutrition and preventive medicine in the last few decades have all helped in increasing life expectancy WW.  However, this has not translated in any reduction in the incidences or prevalence of chronic or critical illnesses! On the contrary, the incidence of chronic diseases like diabetes, obesity, arthritis etc.
$3,000.00
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

Date Published: Jan 22 2015
While targeting unmet needs in the treatment of hematological malignancies/ cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies is dependent on the identification of important genomic alterations in cancerous cells that allow for the tumor’s sub classification.  Over the past decade, Proteasome inhibitor and the immunomodulatory drugs have become the cornerstone of treatment for pts with Multiple Myeloma (MM) resulting in improved survival.
$3,000.00
Global Equine Healthcare Market 2015-2019

Global Equine Healthcare Market 2015-2019

Date Published: Jan 21 2015

About Equine Healthcare

$2,500.00
2015 Deep Market Research Report on Global Semiconductor Laser Therapeutic Device Industry

2015 Deep Market Research Report on Global Semiconductor Laser Therapeutic Device Industry

Date Published: Jan 21 2015

2015 Market Research Report on Global Semiconductor Laser Therapeutic Device Industry is a professional and depth research report on Global Semiconductor Laser Therapeutic Device industry

For overview analysis, the report introduces Semiconductor Laser Therapeutic Device basic information including definition, classification, application, industry
chain structure, industry overview, policy analysis, and news analysis, etc

$2,600.00
Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets

Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets

Date Published: Jan 21 2015
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly.
$2,000.00
Global Anxiety Disorders Market 2015-2019

Global Anxiety Disorders Market 2015-2019

Date Published: Jan 14 2015
Report forecast the Global Anxiety Disorders market to grow at a CAGR of 4.02 percent over the period 2014-2019.
 
$2,500.00
Therapeutic Class Overview : Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

Date Published: Jan 14 2015
Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated with significant adverse effects or abuse liability, and do not reduce pain in all treated individuals. Opioids (e.g., morphine, codeine, oxycodone) are currently one of the most potent groups of analgesics used clinically, with prescriptions increasing by 50% over the past 10 years for chronic, non-cancer pain.
$3,000.00
Epilepsy Market in the US 2015-2019

Epilepsy Market in the US 2015-2019

Date Published: Jan 7 2015
Report forecast the Epilepsy market in the US to grow at a CAGR of 4.85 percent over the period 2014-2019
 
$2,500.00
Global Ankylosing Spondylitis Market 2015-2019

Global Ankylosing Spondylitis Market 2015-2019

Date Published: Jan 7 2015

About Ankylosing Spondylitis

$3,000.00
Sickle-cell Anemia Therapeutics Market in the US 2015-2019

Sickle-cell Anemia Therapeutics Market in the US 2015-2019

Date Published: Jan 7 2015

About Sickle-cell Anemia
Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to compensate for the excessive loss of erythrocytes, thereby leading to anemia. It is an inheritable disorder passed on across generations. The prevalence of the sickle-cell gene varies between different ethnic groups and geographical locations.

$2,500.00
Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

Date Published: Dec 24 2014

A Pipeline Landscape Analysis and Comparative Assessment of Key Players:

$2,680.00
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

Date Published: Nov 30 2014
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 Increasing Uptake of Novel Drug Classes to Drive Market Growth report provides insights into type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan and Australia. The report estimates the market size for 2013 and provides a forecast until 2020, and covers disease epidemiology, treatment algorithms, and treatment use patterns. It also provides in-depth analysis of the pipeline molecules, clinical trial failure rates, and recent deals.
$4,995.00
Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
PharmaPoint: Colorectal Cancer - Current and Future Players

PharmaPoint: Colorectal Cancer - Current and Future Players

Date Published: Nov 28 2014
$2,995.00
Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$4,995.00
Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data